FDA approved PEGylated Products
Since 1990, PEGylated biopharmaceuticals have been introduced into the marketplace as drugs for human use. Most are PEGylated proteins and one is a PEGylated aptamer (Macugen®) administered intravitreally. The PEG components of these biopharmaceuticals vary widely in size, branching structure and attachment type.
Table 1 Marketed PEGylated Products.
Functional Group on PEG: Succinimidyl ester; Aldehyde; Maleimide
Adagen® & Oncaspar®
First 2 marketed PEG protein products through PEGylation technique are pegademase (Adagen®) and pegaspargase (Oncaspar®), which results in a stable amide linkage of multiple PEGs attached to the protein ε-lysines. Information on toxicities of these two pharmaceuticals was not available on the FDA web pages.
Krystexxa®

Krystexxa® (Pegloticase) is mammalian engineered uricase (urate oxidase) used to treat gout. Humans do not naturally have the enzyme, and nonmammalian sources of the enzyme are highly immunogenic. PEGylation of the mammalian-derived enzyme may reduce some of the immunogenicity but does not eliminate it completely.
PEG-Intron®
Fig. 1 PEGylation route for PEG-Intron® synthesis.
PEG-Intron®, a mono-PEGylated INF-a2b, is synthesized by using a succinimidyl carbonate PEG with12 kDa. The mPEG reagent forms a covalent carbamate and/or urethane linker with amine groups on the protein. The PEG-Intron® consists of 14 positional isomers and the distribution of positional isomers is dependent on the PEGylation reaction pH value.
Pegasys®

Pegasys® (PEG INF-a2a) is mono-PEGylated with a single 40-kDa branched PEG, consisting of 4 major positional isomers, Lys31, Lys121, Lys131, and Lys134, which is approved for the treatment of patients with chronic hepatitis C or chronic hepatitis B. The branching PEG structure, as shown on the left, was achieved by using lysine to link the 2 PEG chains.
Mircera®

Mircera® (mPEG-Epoetin Beta) is a mono-PEGylated extended half-life version using mPEG succinimidyl butanoate (30 kDa PEG). PEGylation occurs primarily at Lys 52 and Lys 56.
Omontys® (Recalled in 2014)
Omontys® (Peginesitide), is a PEGylated peptide that has no sequence homology to erythropoietin. It consists of 2 identical 21 amino acid chains peptides, covalently bound via a linker to a 40-kDa lysine branched PEG for a 45 kDa overall size. The structure of Omontys® is unique in that a linker comprised iminodiacetic acid and b alanine is used to connect the 2 peptides creating a peptide dimer. The peptide dimer is then connected by a single coupling point to the branches, which guarantee the construction of the linker only have one positional isomer.
Macugen®
Macugen® (Pegaptanib) is a PEGylated 28 nucleotide aptamer for intravitreal treatment of wet age-related macular degeneration in the eye. Aptamers generally have a short half-life in vivo as they are subject to cleavage by nucleases. PEG, in this case, is a good modifier to to make them suitable for a pharmaceutical product. The candidate which was most effective at inhibiting in vivo vascular leakage (guinea pig model) was chosen for PEGylation with a single 40-kDa lysine branched PEG attached to an amine at the 5’ end.
Neulasta®

Neulasta® (Pegfilgrastim) is a PEGylated form of recombinant human granulocyte colony-stimulating factor (GCSF) and was approved for the treatment of neutropenia. Neulasta® is made with 20-kDa PEG and application of aldehyde chemistry using selective N terminal amine conjugation at low pH.
Plegridy®

Plegridy® (Peginterferon Beta-1) is an INF beta-1a to which a single, linear 20 kDa mPEG-O-2-methylpropionaldehyde molecule (as shown in the left) is covalently attached to the α-NH2 group of amino acid residue via reductive amination with sodium cyanoborohydride. The non-PEGylated IFN b-1a is also marketed under the name Avonex® (IFN b-1a) for the same indication.
Cimzia®

Cimzia® (Certolizumab Pegol) has an engineered thiol for PEGylation, which is the only thiol-engineered PEG conjugate currently marketed. Coupling chemistries that bind PEG to free thiol groups in the protein yield a disulfide linked conjugate. Thiol-reactive agents may provide site-selective PEGylation limiting the number of positional isomers.
References
- Hamidi, M.; Azadi, A.; et al. Pharmacokinetic consequences of pegylation. Drug delivery 2006, 13 (6), 399-409.
- Turecek, P. L.; Bossard, M. J.; et al. PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs. Journal of pharmaceutical sciences 2016, 105 (2), 460-475.
- Dozier, J. K.; Distefano, M. D., Site-specific PEGylation of therapeutic proteins. International journal of molecular sciences 2015, 16 (10), 25831-25864.
Why BOC Sciences?
-
Large Stock
More than 2000+ products in inventory
-
Global Delivery
Warehouses in multiple cities to ensure fast delivery
-
mg to kg
Multi specification for academic research and industrial production
-
24/7 Technical Support
Strict process parameter control to ensure product quality
Technical Support
- Aqueous Two-Phase System (ATPS) Technique
- Capillary Electrophoresis (CE) Technique
- Enzyme-linked immunosorbent assay (ELISA) Technique
- High performance liquid chromatography (HPLC) Technique
- Hydrophobic Interaction Chromatography (HIC) Technique
- PEGylated Protein Purification Techniques
- Radiolabeling Technique
- SDS-PAGE Technique
- Ultrafiltration Technique
Products
- Lipids
- PEG Derivatives by Structure
-
PEG Derivatives by Functional Group
- Acrylate/Acrylamide/Methacrylate PEG
- Aldehyde (Ald/CHO)PEG
- Alkyne PEG
- Amino PEG, PEG amine(-NH2)
- Azide PEG, Azido PEG(-N3)
- Biotin PEG
- Boc/Fmoc protected amine PEG
- Carboxylic Acid(-COOH) PEG
- Cholesterol PEG
- DBCO PEG
- DSPE PEG
- Epoxide glycidyl ether PEG
- FITC PEG
- Halide (chloride, bromide) PEG
- Hydrazide PEG
- Hydroxyl(-OH) PEG
- Maleimide(-MAL) PEG
- Multi-Arm PEG
- NHS ester PEG
- Nitrophenyl carbonate (NPC) PEG
- Norbornene PEG
- Olefin/Alkene/Vinyl PEG
- Orthopyridyl disulfide (OPSS) PEG
- Phosphate PEG
- Rhodamine PEG
- SCM PEG
- Silane PEG
- Sulfonate (tosyl, mesyl, tresyl) PEG
- tert-Butyl protected carboxylate PEG
- Thiol(-SH) PEG
- Vinylsulfone PEG
- PEG Copolymers
-
PEG Raw Materials
- Small-molecule Polyethylene Glycol
- Polyethylene Glycol 1000
- Polyethylene Glycol 10000
- Polyethylene Glycol 1500
- Polyethylene Glycol 200
- Polyethylene Glycol 2000
- Polyethylene Glycol 20000
- Polyethylene Glycol 400
- Polyethylene Glycol 4000
- Polyethylene Glycol 600
- Polyethylene Glycol 6000
- Polyethylene Glycol 800
- Polyethylene Glycol 8000
Services
- PEGylation Services
- PEGylation Analysis and Method Verification
- Surface Modification and Functionalization
- PEGylated Biodegradable Polymers Synthesis
- Monodisperse PEG Synthesis
- Custom Synthesis PEG Derivatives
- PEG cGMP Manufacture
- PEG Crosslinking Services
Resources
-
Technical Information
- Aqueous Two-Phase System (ATPS) Technique
- Capillary Electrophoresis (CE) Technique
- Enzyme-linked immunosorbent assay (ELISA) Technique
- High performance liquid chromatography (HPLC) Technique
- Hydrophobic Interaction Chromatography (HIC) Technique
- Introduction of Polyethylene Glycol (PEG)
- Ion Exchange Chromatography (IEX) Technique
- PEG for Chemical Synthesis
- PEG for Cosmetic Application
- PEG for Drug Delivery
- PEG for Imaging Diagnosis
- PEG for Pharmaceutical Preparation
- PEG for Tissue Engineering
- PEGylated Protein Purification Techniques
- Radiolabeling Technique
- SDS-PAGE Technique
- Size Exclusion Chromatography (SEC) Technique
- Ultrafiltration Technique
- Industry News
Our Feature
BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.

PEGylation of Peptides
and Proteins
Reduce the Immunogenicity of Peptide/Protein Drugs
Learn More
APPLICATIONS

PEG linkers For Drug
Improved Circulation Half-Life
Learn More
Have Customer Reviewed On Us?
Chat With Us